GB0139

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

A patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2022-present): an update.

Sethi A, Alvala M

Inhibition of Galectin-3 Expression Could Preserve the Immunoregulatory Function of Mesenchymal Stem Cells During Cell Passaging.

Wang M, Jiang Y, Wan J et al.

Binding free energy analysis of galectin-3 natural ligands and synthetic inhibitors.

Newman L, Vaissier Welborn V

Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy.